VENTRICULAR FIBRILLATION DURING AND AFTER CORONARY ARTERY OCCLUSION - INCIDENCE AND PROTECTION AFFORDED BY VARIOUS DRUGS

被引：95

作者：

STEPHENSON, SE

COLE, RK

PARRISH, TF

BAUER, FM

JOHNSON, IT

KOCHTITZKY, M

ANDERSON, JS

HIBBITT, LL

MCCARTY, JE

YOUNG, ER

WILSON, JR

MEIERS, HN

MEADOR, CK

BALL, COT

MENEELY, GR

机构：

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1960年 / 5卷 / 01期

关键词：

D O I：

10.1016/0002-9149(60)90012-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：77 / 87

页数：11

共 61 条

[31]

Kochmann M, 1908, ARCH INT PHARMACOD T, V18, P41

[32]

LERICHE R, 1933, ACTA CHIR SCAND, V70, P260

[33]

Levy AG, 1913, HEART-J STUD CIRC, V4, P319

[34]

Levy AG, 1914, HEART-J STUD CIRC, V5, P299

[35] PROTECTIVE AGENTS FOR EPINEPHRINE CYCLOPROPANE-INDUCED CARDIAC ARRHYTHMIAS [J].

MCCAWLEY, EL ;

WHITE, JM ;

DAVID, NA .

AMERICAN JOURNAL OF MEDICINE, 1950, 8 (04) :526-526

[36]

MENEELY GR, 1946, FED PROC, V5, P226

[37]

MENEELY GR, 1952, FED PROC, V11, P106

[38]

MENEELY GR, 1950, AM J MED, V9, P262

[39] Ventricular fibrillation as the mechanism of sudden death in patients with coronary occlusion [J].

Miller, H .

NEW ENGLAND JOURNAL OF MEDICINE, 1939, 221 :564-569

[40]

Miller JL, 1909, ARCH INTERN MED, V3, P476

← 1 2 3 4 5 6 7 →